Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2022 Q1- Text added to 2022 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
abaloparatide, adult, AEs, analog, appeal, AUC, awaiting, bear, bilateral, bloating, BMD, bone, Cmax, covenant, creditor, curve, density, drew, DS, female, flexibility, Forteo, intact, intraperitoneal, IP, Journal, landlord, merge, mineral, oabaloparatide, ocreotide, oophorectomy, ovariectomy, OVX, PD, peak, pharmacodynamic, PK, proceed, prospect, rat, revoked, rodent, SC, serum, sham, sterile, stomach, substance, surgery, teriparatide, tranche, uncommitted, undergoing, vi, vomiting, withheld, women
Valuein 2022 Q1 filing- Value in 2022 Q2 filing
Original filings
Filing view